EP Patent

EP1751148A1 — Ziprasidone hydrochloride polymorph and process for its preparation

Assigned to Dipharma Francis SRL · Expires 2007-02-14 · 19y expired

What this patent protects

New crystalline form of ziprasidone hydrochloride hemihydrate, process for its preparation, its use for the purification of ziprasidone, its pharmaceutical compositions and their use in therapy.

USPTO Abstract

New crystalline form of ziprasidone hydrochloride hemihydrate, process for its preparation, its use for the purification of ziprasidone, its pharmaceutical compositions and their use in therapy.

Drugs covered by this patent

Patent Metadata

Patent number
EP1751148A1
Jurisdiction
EP
Classification
—
Expires
2007-02-14
Drug substance claim
No
Drug product claim
No
Assignee
Dipharma Francis SRL
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.